Clinical Trials on Secondary Hypogammaglobulinemia

Total 1545 results

Centre Hospitalier Universitaire, Amiens
Binding site

Recruiting

The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases (ISOHYPE)

Autoimmune Diseases | Polyclonal Hypergammaglobulinemia

France
Turku University Hospital

Unknown

Clinical and Virological Efficacy of Pegylated Interferon Alpha in the Treatment of Rhinovirus Infection in Patients With Primary Hypogammaglobulinemia: Randomized Controlled Trial (Hypogamma Int1)

Rhinovirus Infection

Finland
The Second Hospital of Nanjing Medical University

Recruiting

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism;Parathyroidectomy

China
Phramongkutklao College of Medicine and Hospital

Completed

Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Chang Gung Memorial Hospital

Completed

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

Secondary Hyperparathyroidism Due to Renal Causes

Taiwan
Fundación Senefro
AbbVie; Effice Servicios Para la Investigacion S.L.

Completed

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. (PARIDOINAL)

Secondary Hyperparathyroidism Due to Renal Causes

Spain
Shanghai Zhongshan Hospital

Unknown

Preemptive and Precise Intervention for CKD-SHPT

Hyperparathyroidism; Secondary, Renal
Federal University of Pelotas

Active, not recruiting

Caries Cognition and Identification in Adults (CaCIA)

Secondary Caries

Brazil
Jazz Pharmaceuticals

Approved for marketing

EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML (401)

Secondary AML

United States
Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

The Trial of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase 3 Study of SK-1403

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism

Japan
Deltanoid Pharmaceuticals

Completed

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Penang Hospital, Malaysia
Ministry of Health, Malaysia

Unknown

Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients

Secondary Hyperparathyroidism

Malaysia
Seoul National University Hospital
Jeil-Kirin Pharmaceutical Inc.

Completed

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level (CUPID)

Secondary Hyperparathyroidism

Korea, Republic of
China-Japan Friendship Hospital

Recruiting

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.

Completed

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Secondary Hyperparathyroidism

China, Hong Kong, Korea, Republic of, Taiwan
Hospital General Ajusco Medio

Completed

IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Mexico
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kumamoto University

Completed

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

Japan
Abbott
Statistika Consultoria Ltda

Terminated

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

Secondary Hyperparathyroidism | Dialysis

Brazil
Abbott

Completed

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

Secondary Hyperparathyroidism | Dialysis

Mexico
Cairo University

Unknown

Reliability of Secondary Caries Detection Around Composite Restoration Using Light Induced Fluorescence

Secondary Caries

Egypt
Mersin University

Completed

Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism | Myocardial Dysfunction

Turkey
Min-Sheng General Hospital
Taipei Medical University; Taipei Medical University Shuang Ho Hospital; National... and other collaborators

Completed

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Hyperparathyroidism; Secondary, Renal

Taiwan
Wenhu Liu

Unknown

The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Secondary Hyperparathyroidism | Maintenance Hemodialysis

China
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Papageorgiou General Hospital

Terminated

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Secondary Hyperparathyroidism

Greece
Fifth Affiliated Hospital, Sun Yat-Sen University

Completed

Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

Secondary Hyperparathyroidism | Parathyroid Gland Disease

China
Vestre Viken Hospital Trust
Oslo University Hospital; The Hospital of Vestfold; Kalmar County Hospital

Completed

The NOR-COR Study for Coronary Prevention

Secondary Coronary Prevention

Norway
Beijing Friendship Hospital

Unknown

the Study on Prognostic for Hemodialysis Patients

Secondary Hyperparathyroidism

China
Josep M Cruzado

Completed

Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation

Secondary Hyperparathyroidism

Spain
Mario Negri Institute for Pharmacological Research

Completed

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (APPLE)

Renal Transplant | Secondary Hyperparathyroidism

Italy
Imperial College London
University College, London

Completed

Screening Women for Functional Hypothalamic Amenorrhea (FHA)

Amenorrhea Secondary

United Kingdom
Kyowa Kirin China Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)

Hyperparathyroidism; Secondary, Renal

China
China National Center for Cardiovascular Diseases

Completed

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1)

Coronary Artery Bypass Grafting | Secondary Preventions

China
Cairo University

Recruiting

Validity of Fluorescence-Based Devices Versus Visual-Tactile Method in Detection of Secondary Caries Around Resin Composite Restorations: Invivo Diagnostic Accuracy Study

Secondary Caries Around Resin Composite Restorations

Egypt
University of Maryland, Baltimore

Completed

Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism (1hydroxylase)

Secondary Hyperparathyroidism

United States
Papageorgiou General Hospital

Completed

Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
Bio Products Laboratory

Completed

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Primary Immunodeficiency | Wiskott-Aldrich Syndrome | Hypogammaglobulinemia | Common Variable Hypogammaglobulinemia | X-linked Hypogammaglobulinemia | Immunodeficiency With Hyper-IgM

United States
TherapeuticsMD

Terminated

A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea (SPRY)

Secondary Amenorrhea

United States
Solvay Pharmaceuticals

Completed

Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion

Secondary Amenorrhea

United States
Karnataka Health Promotion Trust
London School of Hygiene and Tropical Medicine; University of Manitoba

Completed

Evaluation of an Intervention for Adolescent Girls in Karnataka (Samata)

Child Marriage | Secondary School Entry and Completion

India
Kyowa Kirin Co., Ltd.

Completed

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Hyperparathyroidism

Japan

Clinical Trials on Secondary Hypogammaglobulinemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations